Senior insider sale
Chief Commercial Officer at ARS PHARMACEUTICALS, INC. — senior position signals high conviction
$250.0K
25K shares
What this filing means
KARAS ERIC plans to sell 25K shares of ARS PHARMACEUTICALS, INC. valued at approximately $250.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/12/2026ACC: 0001950047-26-006004
Officer· Chief Commercial Officer
Since Nov 2022
25K
Shares to sell
$250.0K
Approx. market value
25K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
6/12/2026
25KTotal acquired25K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/12/2026 | Stock Option Exercise Cash | 25K | — |
| Total | 25K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
25K
Market value
$250.0K
6/12/2026
Total
Units
25K
Value
$250.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/12/2026 | 25K | $250.0K | NASDAQ | Planned |
| Total | 25K | $250.0K | ||